Morgan Stanley Assumes BeiGene, Ltd. (BGNE) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
BeiGene, Ltd. (BGNE) PT Raised to $207 at Bernstein SocGen Group
November 29, 2024 8:35 AM ESTBernstein SocGen Group analyst Rebecca Liang raised the price target on BeiGene, Ltd. (NASDAQ: BGNE) to $207.00 while maintaining a Market Perform rating.
The analyst said: "In this model update of BeiGene post-earnings, we present a new, integrated B-cell malignancies market model covering... More
